![128796-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2021-04/128796-Thumbnail%20Image.png?versionId=hRgY.oLZ36ZDBdozpKzYJ0.d7b7YzMcn&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240615/us-west-2/s3/aws4_request&X-Amz-Date=20240615T230226Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=e9b8956b08fc317b8b6d00db02bc363a2e09bc5abfeeb642479d015a0fef6edc&itok=2MJrqt2B)
Methicillin resistant Staphylococcus aureus (MRSA) is currently a major cause of skin and soft tissue infections (SSTI) in the United States. Seasonal variation of MRSA infections in hospital settings has been widely observed. However, systematic time-series analysis of incidence data is desirable to understand the seasonality of community acquired (CA)-MRSA infections at the population level. In this paper, using data on monthly SSTI incidence in children aged 0–19 years and enrolled in Medicaid in Maricopa County, Arizona, from January 2005 to December 2008, we carried out time-series and nonlinear regression analysis to determine the periodicity, trend, and peak timing in SSTI incidence in children at different age: 0-4 years, 5-9 years, 10-14 years, and 15-19 years. We also assessed the temporal correlation between SSTI incidence and meteorological variables including average temperature and humidity. Our analysis revealed a strong annual seasonal pattern of SSTI incidence with peak occurring in early September. This pattern was consistent across age groups. Moreover, SSTIs followed a significantly increasing trend over the 4-year study period with annual incidence increasing from 3.36% to 5.55% in our pediatric population of approximately 290,000. We also found a significant correlation between the temporal variation in SSTI incidence and mean temperature and specific humidity. Our findings could have potential implications on prevention and control efforts against CA-MRSA.
![128802-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2021-04/128802-Thumbnail%20Image.png?versionId=yoReL1VzcO9qGhBvwMj2XLKemzkpDcdn&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240616/us-west-2/s3/aws4_request&X-Amz-Date=20240616T021432Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=6e3b7ef5a84f6c7123c269f79f82a84a99b0556c4bf10556f7f51dd8f7afa3b1&itok=JDIQOneN)
The large-scale use of antivirals during influenza pandemics poses a significant selection pressure for drug-resistant pathogens to emerge and spread in a population. This requires treatment strategies to minimize total infections as well as the emergence of resistance. Here we propose a mathematical model in which individuals infected with wild-type influenza, if treated, can develop de novo resistance and further spread the resistant pathogen. Our main purpose is to explore the impact of two important factors influencing treatment effectiveness: i) the relative transmissibility of the drug-resistant strain to wild-type, and ii) the frequency of de novo resistance. For the endemic scenario, we find a condition between these two parameters that indicates whether treatment regimes will be most beneficial at intermediate or more extreme values (e.g., the fraction of infected that are treated). Moreover, we present analytical expressions for effective treatment regimes and provide evidence of its applicability across a range of modeling scenarios: endemic behavior with deterministic homogeneous mixing, and single-epidemic behavior with deterministic homogeneous mixing and stochastic heterogeneous mixing. Therefore, our results provide insights for the control of drug-resistance in influenza across time scales.
![128811-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2021-04/128811-Thumbnail%20Image.png?versionId=HLWyQ2RBs6VX8dgOBt7DyrreiUTTZhn_&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240616/us-west-2/s3/aws4_request&X-Amz-Date=20240616T055529Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=74f1a5ccb2763bc34a1db8681757a8abe4802f74de5c5ac0cff45c75d62f1ca6&itok=H85zyB8S)
The Middle Stone Age (MSA) is associated with early evidence for symbolic material culture and complex technological innovations. However, one of the most visible aspects of MSA technologies are unretouched triangular stone points that appear in the archaeological record as early as 500,000 years ago in Africa and persist throughout the MSA. How these tools were being used and discarded across a changing Pleistocene landscape can provide insight into how MSA populations prioritized technological and foraging decisions. Creating inferential links between experimental and archaeological tool use helps to establish prehistoric tool function, but is complicated by the overlaying of post-depositional damage onto behaviorally worn tools. Taphonomic damage patterning can provide insight into site formation history, but may preclude behavioral interpretations of tool function. Here, multiple experimental processes that form edge damage on unretouched lithic points from taphonomic and behavioral processes are presented. These provide experimental distributions of wear on tool edges from known processes that are then quantitatively compared to the archaeological patterning of stone point edge damage from three MSA lithic assemblages—Kathu Pan 1, Pinnacle Point Cave 13B, and Die Kelders Cave 1. By using a model-fitting approach, the results presented here provide evidence for variable MSA behavioral strategies of stone point utilization on the landscape consistent with armature tips at KP1, and cutting tools at PP13B and DK1, as well as damage contributions from post-depositional sources across assemblages. This study provides a method with which landscape-scale questions of early modern human tool-use and site-use can be addressed.
![135504-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2021-05/135504-Thumbnail%20Image.png?versionId=i9A89UyGDaiT8zJXPT6sgi_fdWO1ksgg&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240616/us-west-2/s3/aws4_request&X-Amz-Date=20240616T062808Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=bc7d98c89f072d7ec6dfafe5c07cabb62d9301323042ae6c361f2678f20a43e3&itok=i7KULznM)
![135530-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2021-05/135530-Thumbnail%20Image.png?versionId=BHtsZg.5wztJqNxyxDU6mZKNVIPdicyh&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240615/us-west-2/s3/aws4_request&X-Amz-Date=20240615T194348Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=14873c10a0b36f2404535c3827aee53012766f8d76719c6961e275a700a7bd80&itok=JQD1hdKj)
![136215-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2021-05/136215-Thumbnail%20Image.png?versionId=PTCp67_yTc9kPzqIW6NpknvUYkudwWZ_&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240615/us-west-2/s3/aws4_request&X-Amz-Date=20240615T173814Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=7570299e59bbbabfff0436d78dbbd0ea4369f90b2fc9be9d6ea6f912ecb44218&itok=xN3DsYve)
![136220-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2021-05/136220-Thumbnail%20Image.png?versionId=zJ8bXqPlpGp0K2gbTvlZ8wxIlPgV.UR8&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240615/us-west-2/s3/aws4_request&X-Amz-Date=20240615T204252Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=a86ea78482db410c04c21c364969969425533c7fc4c7f606c2f61989a30c541c&itok=ZdQvIfhr)
![136175-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2021-05/136175-Thumbnail%20Image.png?versionId=fPXAWSlWa4KoPkAOQczYriBsxW1j1DQh&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240616/us-west-2/s3/aws4_request&X-Amz-Date=20240616T033353Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=38510b6323a09071d2e9ddc40c28e718960d04678130b816c68de8e54fcae404&itok=RAk8lD5a)
![133473-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2021-05/133473-Thumbnail%20Image.png?versionId=MvsyvQEEn4wIM_I8y.iJYYnPYOA8gkS4&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240615/us-west-2/s3/aws4_request&X-Amz-Date=20240615T231610Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=cbdc2a5c4b86f7ec97aea6062e135ac7032a01df77035c3518d83acbc265a07e&itok=xnR18FJo)
![133476-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2021-05/133476-Thumbnail%20Image.png?versionId=xAUMe4oxRz3ZpPLkxBF4Y.DpP6yctTDB&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240616/us-west-2/s3/aws4_request&X-Amz-Date=20240616T004825Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=cf4e345055f06d50668144932e2bec16ac6e127da335d8f051a730b08896f171&itok=0ny_6CBz)